ProQR Therapeutics (PRQR)
(Delayed Data from NSDQ)
$1.73 USD
-0.05 (-2.81%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $1.72 -0.01 (-0.58%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2024
Time: -- |
9/2024 | $-0.12 | 0.00% |
Earnings Summary
For their last quarter, ProQR Therapeutics (PRQR) reported earnings of -$0.03 per share, beating the Zacks Consensus Estimate of $-0.12 per share. This reflects a positive earnings surprise of 75.00%. Look out for PRQR's next earnings release expected on November 05, 2024. For the next earning release, we expect the company to report earnings of -$0.12 per share, reflecting a year-over-year decrease of 50%.
Earnings History
Price & Consensus
Zacks News for PRQR
Regenxbio (RGNX) Soars 6.4%: Is Further Upside Left in the Stock?
PRQR: What are Zacks experts saying now?
Zacks Private Portfolio Services